Stay updated on Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Sign up to get notified when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.

Latest updates to the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier changed from v3.7.2 to v3.8.0. The study record still displays a 403 Forbidden page.SummaryDifference0.2%

- Check8 days agoChange DetectedA site-wide NIH banner announces a transition from the term “Artificial Intelligence” to “Super Intelligence” and links to related updates and FAQs.SummaryDifference1%

- Check14 days agoChange DetectedThe footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedThe site footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check42 days agoChange DetectedAccess to the study record has been blocked by a 403 Forbidden error, replacing the detailed study information with an error page. Users can no longer view the study content, documents, or location details that were previously listed.SummaryDifference20%

- Check64 days agoChange DetectedThe page's revision label was updated from v3.6.5 to v3.6.6. This indicates a minor update to the page framework or content version rather than changes to study details or eligibility information.SummaryDifference0.0%

Stay in the know with updates to Study CB-839 + Paclitaxel in TNBC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Study CB-839 + Paclitaxel in TNBC: Clinical Trial page.